Chemical Translational Biology: Redefining Druggability of Protein-Protein Interactions

被引:1
作者
Cesa, Laura C. [1 ]
机构
[1] Univ Copenhagen, Ctr Biopharmaceut, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark
关键词
allostery; chemical biology; drug discovery; protein-protein interactions; INHIBITORS; DISCOVERY; IDENTIFICATION; ACTIVATION; PPIS;
D O I
10.1002/cbic.202000532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemical biologists use chemical tools to answer biological questions. The translational application of these principles has led to an explosion in the discovery and druggability of new protein targets, including protein-protein interactions (PPIs). Proteins tend to interact with other macromolecules using relatively large and featureless binding surfaces, which has hampered traditional drug discovery efforts, particularly for interactions with weaker affinity. In this article, I discuss several emerging strategies for targeting PPIs, including computational and structural methods and novel screening approaches. In particular, I focus on hijacking intrinsic protein allosteric pathways for the discovery and design of small-molecule and peptide ligands.
引用
收藏
页码:985 / 987
页数:3
相关论文
共 50 条
[41]   Using a Fragment-Based Approach To Target Protein-Protein Interactions [J].
Scott, Duncan E. ;
Ehebauer, Matthias T. ;
Pukala, Tara ;
Marsh, May ;
Blundell, Tom L. ;
Venkitaraman, Ashok R. ;
Abell, Chris ;
Hyvoenen, Marko .
CHEMBIOCHEM, 2013, 14 (03) :332-342
[42]   Using Fragment-Based Technologies to Target Protein-Protein Interactions [J].
Bower, Justin F. ;
Pannifer, Andrew .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) :4685-4696
[43]   Prediction of protein-protein interactions by label propagation with protein evolutionary and chemical information derived from heterogeneous network [J].
Wen, Yu-Ting ;
Lei, Hai-Jun ;
You, Zhu-Hong ;
Lei, Bai-Ying ;
Chen, Xing ;
Li, Li-Ping .
JOURNAL OF THEORETICAL BIOLOGY, 2017, 430 :9-20
[44]   Structure-based assessment and druggability classification of protein-protein interaction sites [J].
Alzyoud, Lara ;
Bryce, Richard A. ;
Al Sorkhy, Mohammad ;
Atatreh, Noor ;
Ghattas, Mohammad A. .
SCIENTIFIC REPORTS, 2022, 12 (01)
[45]   Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein-protein interactions of 14-3-3 [J].
Hartman, Alwin M. ;
Hirsch, Anna K. H. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 136 :573-584
[46]   Targeting intracellular protein-protein interactions with macrocyclic peptides [J].
Buyanova, Marina ;
Pei, Dehua .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (03) :234-248
[47]   Motif mediated protein-protein interactions as drug targets [J].
Carles Corbi-Verge ;
Philip M. Kim .
Cell Communication and Signaling, 14
[48]   Databases of protein-protein interactions and their use in drug discovery [J].
Fuentes, Gloria ;
Oyarzabal, Julen ;
Rojas, Ana M. .
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (03) :358-366
[49]   Peptides and Peptide Analogs to Inhibit Protein-Protein Interactions [J].
Helmer, Dorothea ;
Schmitz, Katja .
PROTEIN TARGETING COMPOUNDS: PREDICTION, SELECTION AND ACTIVITY OF SPECIFIC INHIBITORS, 2016, 917 :147-183
[50]   Alternative modulation of protein-protein interactions by small molecules [J].
Fischer, Gerhard ;
Rossmann, Maxim ;
Hyvoenen, Marko .
CURRENT OPINION IN BIOTECHNOLOGY, 2015, 35 :78-85